Kari Saunamäki

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist et al. · The Lancet · 2015 · 966 citations

Medicine, Cardiology, Internal Medicine +16

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 546 citations · Full text

Medicine, Cardiology, Pharmacology +16

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

David Erlinge, Akiko Maehara, Ori Ben‐Yehuda et al. · The Lancet · 2021 · 477 citations · Full text

Medicine, Cardiology, Diagnostic Imaging +16

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

Frants Pedersen, Vitalij Butrymovich, Henning Kelbæk et al. · Journal of the American College of Cardiology · 2014 · 424 citations

Medicine, Cardiology, Internal Medicine +5

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Derek J. Hausenloy, Rajesh Kharbanda, Ulla Møller et al. · The Lancet · 2019 · 324 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16